Quality of life during first-line FOLFOX4±panitumumab in RAS wild-type metastatic colorectal carcinoma: results from a randomised controlled trial

Por Siena, Salvatore, Tabernero, Josep, Bodoky, Gyorgy, Cunningham, David, Rivera, Fernando, Ruff, Paul, Canon, Jean Luc, Koukakis, Reija, Demonty, Gaston, Hechmati, Guy, Douillard, Jean-Yves
Publicado no ESMO Open (2016)

Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancer

Por Toffoli, Sébastien, Bar, Isabelle, Abdel-Sater, Fadi, Delrée, Paul, Hilbert, Pascale, Cavallin, Frédéric, Moreau, Fabrice, Van Criekinge, Wim, Lacroix-Triki, Magali, Campone, Mario, Martin, Anne-Laure, Roché, Henri, Machiels, Jean-Pascal, Carrasco, Javier, Canon, Jean-Luc
Publicado no Breast Cancer Res (2014)

Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasi...

Por De Grève, Jacques, Van Meerbeeck, Jan, Vansteenkiste, Johan F., Decoster, Lore, Meert, Anne-Pascale, Vuylsteke, Peter, Focan, Christian, Canon, Jean-Luc, Humblet, Yves, Berchem, Guy, Colinet, Benoit, Galdermans, Danny, Bosquée, Lionel, Vermeij, Joanna, Dewaele, Alex, Geers, Caroline, Schallier, Denis, Teugels, Erik
Publicado no PLoS One (2016)

Extended Benefit from Sequential Administration of Docetaxel after Standard Fluorouracil, Epirubicin, and Cyclophosphamide Regimen for Node-Positive Breast Cancer: The 8-Year Follo...

Por Coudert, Bruno, Asselain, Bernard, Campone, Mario, Spielmann, Marc, Machiels, Jean-Pascal, Pénault-Llorca, Frédérique, Serin, Daniel, Lévy, Christelle, Romieu, Gilles, Canon, Jean-Luc, Orfeuvre, Hubert, Piot, Gilles, Petit, Thierry, Jerusalem, Guy, Audhuy, Bruno, Veyret, Corinne, Beauduin, Marc, Eymard, Jean-Christophe, Martin, Anne-Laure, Roché, Henri
Publicado em 2012

A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer

Por Schuler, Martin, Awada, Ahmad, Harter, Philipp, Canon, Jean Luc, Possinger, Kurt, Schmidt, Marcus, De Grève, Jacques, Neven, Patrick, Dirix, Luc, Jonat, Walter, Beckmann, Matthias W., Schütte, Jochen, Fasching, Peter A., Gottschalk, Nina, Besse-Hammer, Tatiana, Fleischer, Frank, Wind, Sven, Uttenreuther-Fischer, Martina, Piccart, Martine, Harbeck, Nadia
Publicado em 2012

Safety and Efficacy of Buparlisib (BKM120) in Patients with PI3K Pathway-Activated Non-Small Cell Lung Cancer: Results from the Phase II BASALT-1 Study

Por Vansteenkiste, Johan F., Canon, Jean-Luc, De Braud, Filippo, Grossi, Francesco, De Pas, Tommaso, Gray, Jhanelle E., Su, Wu-Chou, Felip, Enriqueta, Yoshioka, Hiroshige, Gridelli, Cesare, Dy, Grace K., Thongprasert, Sumitra, Reck, Martin, Aimone, Paola, Vidam, Gena Atalla, Roussou, Pantelia, Wang, Ying A., Tomaso, Emmanuelle Di, Soria, Jean-Charles
Publicado no J Thorac Oncol (2015)

Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast Cancer

Por Metzger-Filho, Otto, Catteau, Aurélie, Michiels, Stefan, Buyse, Marc, Ignatiadis, Michail, Saini, Kamal S., de Azambuja, Evandro, Fasolo, Virginie, Naji, Sihem, Canon, Jean Luc, Delrée, Paul, Coibion, Michel, Cusumano, Pino, Jossa, Veronique, Kains, Jean Pierre, Larsimont, Denis, Richard, Vincent, Faverly, Daniel, Cornez, Nathalie, Vuylsteke, Peter, Vanderschueren, Brigitte, Peyro-Saint-Paul, Hélène, Piccart, Martine, Sotiriou, Christos
Publicado em 2013